Variant report
Variant | nsv1012295 |
---|---|
Chromosome Location | chr2:184789448-184802429 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ZNF804A-2 | chr2:184799099-184799228 | NONHSAT075946 |
2 | lnc-ZNF804A-2 | chr2:184799100-184799228 | XLOC_001779 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571659159 | chr2:184791422-184791423 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540532182 | chr2:184791448-184791449 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs372798932 | chr2:184791476-184791477 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181737933 | chr2:184791477-184791478 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147946515 | chr2:184791580-184791581 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs826120 | chr2:184791585-184791586 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs534664738 | chr2:184791604-184791605 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562933863 | chr2:184791634-184791635 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs112064220 | chr2:184791655-184791656 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187270392 | chr2:184791659-184791660 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568475985 | chr2:184791723-184791724 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190875422 | chr2:184791769-184791770 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs140340810 | chr2:184791781-184791782 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182313413 | chr2:184791850-184791851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144202568 | chr2:184791865-184791866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556361837 | chr2:184791866-184791867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574623016 | chr2:184791873-184791874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375431070 | chr2:184791876-184791877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs199614397 | chr2:184791878-184791879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs373185281 | chr2:184791884-184791885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543636420 | chr2:184791960-184791961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs576151043 | chr2:184791998-184791999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186976623 | chr2:184792047-184792048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555000847 | chr2:184792068-184792069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs58896937 | chr2:184792090-184792091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147806118 | chr2:184792106-184792107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs826119 | chr2:184792134-184792135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563726037 | chr2:184792144-184792145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577508878 | chr2:184792175-184792176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs189818315 | chr2:184792218-184792219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183149764 | chr2:184792244-184792245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531773473 | chr2:184792292-184792293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs548716849 | chr2:184792336-184792337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs826118 | chr2:184792340-184792341 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs115407170 | chr2:184792346-184792347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs74915172 | chr2:184792355-184792356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570747442 | chr2:184792398-184792399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs140180644 | chr2:184792419-184792420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549760207 | chr2:184792470-184792471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569840945 | chr2:184792482-184792483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs202177839 | chr2:184792491-184792492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs200311953 | chr2:184792492-184792493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201405235 | chr2:184792493-184792494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs199764580 | chr2:184792494-184792495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs370873688 | chr2:184792495-184792496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs35568758 | chr2:184792499-184792500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34611115 | chr2:184792501-184792502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs535259438 | chr2:184792525-184792526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188188120 | chr2:184792569-184792570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs192940254 | chr2:184792652-184792653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Autism | 22543975 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:184791400-184791600 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr2:184791400-184793200 | Enhancers | Adipose Nuclei | Adipose |
3 | chr2:184791600-184791800 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr2:184791800-184792200 | Enhancers | Duodenum Smooth Muscle | Duodenum |
5 | chr2:184791800-184793000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr2:184792400-184792800 | Enhancers | NH-A | brain |
7 | chr2:184792400-184793600 | Enhancers | Fetal Lung | lung |
8 | chr2:184792600-184793000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr2:184792800-184793000 | ZNF genes & repeats | Psoas Muscle | Psoas |
10 | chr2:184793000-184809000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr2:184794400-184795000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr2:184795800-184796000 | Enhancers | Fetal Lung | lung |
13 | chr2:184800200-184800400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr2:184800400-184802000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
15 | chr2:184802000-184802600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |